or Try an Advanced Search...

    Cellectis Stocks List

    Symbol Grade Name % Change
    CLLS D Cellectis S.A. 0.63
    PSTX D Poseida Therapeutics, Inc. 3.90
    MBIO F Mustang Bio, Inc. -9.79
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Chimeric Antigen Receptor Medicine Cancer Cancer Treatment Immune System Leukemia Solid Tumors Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Adoptive Cell Transfer Biotechnology Blastoma CD19 Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Cell Product Chimeric Antigen Receptor T Cell Chronic Lymphocytic Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Cellectis stocks.

    Symbol Grade Name Weight
    GNOM F Global X Genomics & Biotechnology ETF 0.27
    BTEC C Principal Healthcare Innovators Index ETF 0.07
    IWC C iShares Microcap ETF 0.04
    AVSC C Avantis U.S. Small Cap Equity ETF 0.02
    VTWV C Vanguard Russell 2000 Value ETF 0.02
    View all Cellectis ETFs...
    Compare ETFs
    Compare BTEC to AVSC Compare GNOM to VTWV Compare IWC to AVSC

        Cellectis Stocks Recent News

        Date Stock Title
        Apr 22 CLLS Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Chimeric Antigen Receptor Medicine Cancer Cancer Treatment Immune System Leukemia Solid Tumors Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Adoptive Cell Transfer Biotechnology Blastoma CD19 Cancer Cell Cancer Immunotherapy Cancer Immunotherapy Product Cell Product Chimeric Antigen Receptor T Cell Chronic Lymphocytic Leukemia
        Cellectis

        Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris and New York City.

        More about Cellectis
        Browse All Tags